Effects of a Short Course of Pranlukast Combined with Systemic Corticosteroid on Acute Asthma Exacerbation Induced by Upper Respiratory Tract Infection

References

• GINA Report, Global Strategy for Asthma Management and Prevention. National Institutes of Health, National Heart, Lung, and Blood Institute; Updated 2011.
   Google Scholar
• Lemanske Jr RF. Viruses and asthma: inception, exacerbation, and possible prevention. J Pediatr 2003; 142:S3–S7.
   PubMed Web of Science ®Google Scholar
• Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. Br Med J 1993; 307:982–986.
   PubMed Web of Science ®Google Scholar
• Moore PE, Cunningham G, Calder MM, DeMatteo AD, Jr, Peeples ME, Summar ML, Peebles RS Jr. Respiratory syncytial virus infection reduces beta2-adrenergic responses in human airway smooth muscle. Am J Respir Cell Mol Biol 2006; 35:559–564.
   PubMedGoogle Scholar
• Tauro S, Su YC, Thomas S, Schwarze J, Matthaei KI, Townsend D, Simson L, Tripp RA, Mahalingam S. Molecular and cellular mechanisms in the viral exacerbation of asthma. Microbes Infect 2008; 10:1014–1023
   Google Scholar
• Dimova-Yaneva D, Russell D, Main M, Brooker RJ, Helms PJ. Eosinophil activation and cysteinyl leukotriene production in infants with respiratory syncytial virus bronchiolitis. Clin Exp Allergy 2004; 34:555–558.
   Google Scholar
• Gentile DA, Fireman P, Skoner DP. Elevations of local leukotriene C4 levels during viral upper respiratory tract infections. Ann Allergy Asthma Immunol 2003; 91:270–274
   Google Scholar
• Matsuse H, Kondo Y, Saeki S, Nakata H, Fukushima C, Mizuta Y, Kohno S. Naturally occurring parainfluenza virus 3 infection in adults induces mild exacerbation of asthma associated with increased sputum concentrations of cysteinyl leukotrienes. Int Arch Allergy Immunol 2005; 138:267–272.
   PubMed Web of Science ®Google Scholar
• Dworski R, Fitzgerald GA, Oates JA, Sheller JR. Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med 1994; 149:953–959.
   PubMed Web of Science ®Google Scholar
• Bisgaard H, Zielen S, Garcia-Garcia ML, Johnston SL, Gilles L, Menten J, Tozzi CA, Polos P. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med 2005; 171:315–322.
   PubMed Web of Science ®Google Scholar
• Johnston NW, Mandhane PJ, Dai J, Duncan JM, Greene JM, Lambert K, Sears MR. Attenuation of the September epidemic of asthma exacerbations in children: a randomized, controlled trial of montelukast added to usual therapy. Pediatrics 2007; 120:e702–e712.
   PubMed Web of Science ®Google Scholar
• Robertson CF, Price D, Henry R, Mellis C, Glasgow N, Fitzgerald D, Lee AJ, Turner J, Sant M. Short-course montelukast for intermittent asthma in children: a randomized controlled trial. Am J Respir Crit Care Med 2007; 175:323–329.
   PubMed Web of Science ®Google Scholar
• Kloepfer KM, DeMore JP, Vrtis RF, Swenson CA, Gaworski KL, Bork JA, Evans MD, Gern JE. Effects of montelukast in subjects with asthma after experimental inoculation with Rhinovirus-16. Ann Allergy Asthma Immunol 2011; 106:252–257.
   PubMed Web of Science ®Google Scholar
• Venarske DL, Busse WW, Griffin MR, Gebretsadik T, Shintani AK, Minton PA, Peebles RS, Hamilton R, Weisshaar E, Vrtis R, Higgins SB, Hartert TV. The relationship of rhinovirus-associated asthma hospitalizations with inhaled corticosteroids and smoking. J Infect Dis 2006; 193:1536–1543.
   PubMed Web of Science ®Google Scholar
• Gustafson LM, Proud D, Hendley JO, Hayden FG, Gwaltney Jr JM. Oral prednisone therapy in experimental rhinovirus infections. J Allergy Clin Immunol 1996; 97:1009–1014.
   PubMed Web of Science ®Google Scholar
• Liu Y, Haas DL, Poore S, Isakovic S, Gahan M, Mahalingam S, Fu ZF, Tripp RA. Human metapneumovirus establishes persistent infection in the lungs of mice and is reactivated by glucocorticoid treatment. J Virol 2009; 83:6837–6848.
   PubMed Web of Science ®Google Scholar
• Matsuse H, Kondo Y, Machida I, Kawano T, Saeki S, Tomari S, Obase Y, Fukushima C, Mizuta Y, Kohno S. Effects of anti-inflammatory therapies for recurrent and low-grade respiratory syncytial virus infections in a murine model of asthma. Ann Allergy Asthma Immunol 2006; 97:55–60.
   Google Scholar
• Ramsay CF, Pearson D, Mildenhall S, Wilson AM. Oral montelukast in acute asthma exacerbations: a randomised, double-blind, placebo-controlled trial. Thorax 2011; 66:7–11.
   Google Scholar
• Silverman RA, Nowak RM, Korenblat PE, Skobeloff E, Chen Y, Bonuccelli CM, Miller CJ, Simonson SG. Zafirlukast treatment for acute asthma: evaluation in a randomized, double-blind, multicenter trial. Chest 2004; 126:1480–1489.
   Google Scholar
• Falsey AR, Walsh EE. Respiratory syncytial virus infection in adults. Clin Microbiol Rev 2000; 13:371–384.
   PubMed Web of Science ®Google Scholar
• Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh E. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005; 352:1749–1759.
   PubMed Web of Science ®Google Scholar
• Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001; 344:1917–1928.
   PubMed Web of Science ®Google Scholar
• Behera AK, Kumar M, Matsuse H, Lockey RF, Mohapatra SS. Respiratory syncytial virus induces the expression of 5-lipoxygenase and endothelin-1 in bronchial epithelial cells. Biochem Biophys Res Commun 1998; 251:704–709.
   PubMedGoogle Scholar
• Fleming DM, Pannell RS, Elliot AJ, Cross KW. Respiratory illness associated with influenza and respiratory syncytial virus infection. Arch Dis Child 2005; 90:741–746.
   PubMed Web of Science ®Google Scholar
• Singam R, Jena PK, Behera S, Hellermann GR, Lockey RF, Ledford D, Mohapatra SS. Combined fluticasone propionate and salmeterol reduces RSV infection more effectively than either of them alone in allergen-sensitized mice. Virol J 2006; 3:32.
   Google Scholar